rs2279020

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001127644.2(GABRA1):​c.1059+15G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.646 in 1,601,462 control chromosomes in the GnomAD database, including 336,405 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.63 ( 30064 hom., cov: 32)
Exomes 𝑓: 0.65 ( 306341 hom. )

Consequence

GABRA1
NM_001127644.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.302

Publications

44 publications found
Variant links:
Genes affected
GABRA1 (HGNC:4075): (gamma-aminobutyric acid type A receptor subunit alpha1) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene cause juvenile myoclonic epilepsy and childhood absence epilepsy type 4. Multiple transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008]
GABRA1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 19
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, idiopathic generalized, susceptibility to, 13
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 5-161895883-G-A is Benign according to our data. Variant chr5-161895883-G-A is described in ClinVar as Benign. ClinVar VariationId is 93431.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.693 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127644.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA1
NM_001127644.2
MANE Select
c.1059+15G>A
intron
N/ANP_001121116.1P14867
GABRA1
NM_000806.5
c.1059+15G>A
intron
N/ANP_000797.2A8K177
GABRA1
NM_001127643.2
c.1059+15G>A
intron
N/ANP_001121115.1P14867

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA1
ENST00000393943.10
TSL:1 MANE Select
c.1059+15G>A
intron
N/AENSP00000377517.4P14867
GABRA1
ENST00000023897.10
TSL:1
c.1059+15G>A
intron
N/AENSP00000023897.6P14867
GABRA1
ENST00000428797.7
TSL:1
c.1059+15G>A
intron
N/AENSP00000393097.2P14867

Frequencies

GnomAD3 genomes
AF:
0.625
AC:
95015
AN:
151930
Hom.:
30025
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.599
Gnomad AMI
AF:
0.573
Gnomad AMR
AF:
0.704
Gnomad ASJ
AF:
0.647
Gnomad EAS
AF:
0.463
Gnomad SAS
AF:
0.560
Gnomad FIN
AF:
0.554
Gnomad MID
AF:
0.573
Gnomad NFE
AF:
0.652
Gnomad OTH
AF:
0.625
GnomAD2 exomes
AF:
0.621
AC:
156072
AN:
251212
AF XY:
0.616
show subpopulations
Gnomad AFR exome
AF:
0.600
Gnomad AMR exome
AF:
0.716
Gnomad ASJ exome
AF:
0.654
Gnomad EAS exome
AF:
0.439
Gnomad FIN exome
AF:
0.549
Gnomad NFE exome
AF:
0.650
Gnomad OTH exome
AF:
0.628
GnomAD4 exome
AF:
0.648
AC:
939033
AN:
1449414
Hom.:
306341
Cov.:
30
AF XY:
0.644
AC XY:
465075
AN XY:
721866
show subpopulations
African (AFR)
AF:
0.595
AC:
19738
AN:
33198
American (AMR)
AF:
0.714
AC:
31932
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.652
AC:
16994
AN:
26070
East Asian (EAS)
AF:
0.479
AC:
18983
AN:
39624
South Asian (SAS)
AF:
0.567
AC:
48754
AN:
86006
European-Finnish (FIN)
AF:
0.556
AC:
29682
AN:
53360
Middle Eastern (MID)
AF:
0.590
AC:
3383
AN:
5736
European-Non Finnish (NFE)
AF:
0.665
AC:
731437
AN:
1100726
Other (OTH)
AF:
0.636
AC:
38130
AN:
59982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
15933
31866
47799
63732
79665
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18944
37888
56832
75776
94720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.626
AC:
95111
AN:
152048
Hom.:
30064
Cov.:
32
AF XY:
0.622
AC XY:
46227
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.599
AC:
24836
AN:
41464
American (AMR)
AF:
0.704
AC:
10758
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.647
AC:
2245
AN:
3472
East Asian (EAS)
AF:
0.463
AC:
2393
AN:
5170
South Asian (SAS)
AF:
0.562
AC:
2710
AN:
4824
European-Finnish (FIN)
AF:
0.554
AC:
5843
AN:
10556
Middle Eastern (MID)
AF:
0.578
AC:
170
AN:
294
European-Non Finnish (NFE)
AF:
0.652
AC:
44316
AN:
67968
Other (OTH)
AF:
0.625
AC:
1317
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1839
3678
5517
7356
9195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.642
Hom.:
59315
Bravo
AF:
0.634
Asia WGS
AF:
0.531
AC:
1850
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
1
Developmental and epileptic encephalopathy, 19 (1)
-
-
1
Epilepsy, idiopathic generalized, susceptibility to, 13 (1)
-
-
1
Idiopathic generalized epilepsy;C1970160:Epilepsy, childhood absence 4;C4013473:Epilepsy, idiopathic generalized, susceptibility to, 13 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.96
DANN
Benign
0.17
PhyloP100
0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2279020; hg19: chr5-161322889; COSMIC: COSV50100429; COSMIC: COSV50100429; API